Amniotic Fluid-Derived Stem Cells for Cardiovascular Tissue Engineering Applications
Author(s)
Petsche Connell, Jennifer; Camci-Unal, Gulden; Khademhosseini, Ali; Jacot, Jeffrey G.
DownloadConnell-2013-Amniotic fluid-derived stem cells for cardiovascular tissue engineering applications.pdf (512Kb)
PUBLISHER_POLICY
Publisher Policy
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Terms of use
Metadata
Show full item recordAbstract
Recent research has demonstrated that a population of stem cells can be isolated from amniotic fluid removed by amniocentesis that are broadly multipotent and nontumorogenic. These amniotic fluid-derived stem cells (AFSC) could potentially provide an autologous cell source for treatment of congenital defects identified during gestation, particularly cardiovascular defects. In this review, the various methods of isolating, sorting, and culturing AFSC are compared, along with techniques for inducing differentiation into cardiac myocytes and endothelial cells. Although research has not demonstrated complete and high-yield cardiac differentiation, AFSC have been shown to effectively differentiate into endothelial cells and can effectively support cardiac tissue. Additionally, several tissue engineering and regenerative therapeutic approaches for the use of these cells in heart patches, injection after myocardial infarction, heart valves, vascularized scaffolds, and blood vessels are summarized. These applications show great promise in the treatment of congenital cardiovascular defects, and further studies of isolation, culture, and differentiation of AFSC will help to develop their use for tissue engineering, regenerative medicine, and cardiovascular therapies.
Date issued
2013-03Department
Harvard University--MIT Division of Health Sciences and TechnologyJournal
Tissue Engineering Part B: Reviews
Publisher
Mary Ann Liebert, Inc.
Citation
Petsche Connell, Jennifer, Gulden Camci-Unal, Ali Khademhosseini, and Jeffrey G. Jacot. “Amniotic Fluid-Derived Stem Cells for Cardiovascular Tissue Engineering Applications.” Tissue Engineering Part B: Reviews 19, no. 4 (August 2013): 368-379.
Version: Final published version
ISSN
1937-3368
1937-3376